{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:57:37Z","timestamp":1771484257031,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008590","name":"Dr. Ralph and Marian Falk Medical Research Trust","doi-asserted-by":"publisher","award":["Catalyst Award"],"award-info":[{"award-number":["Catalyst Award"]}],"id":[{"id":"10.13039\/100008590","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mark Weinzierl Research Fund"},{"name":"The Eye Melanoma Research Fund at Thomas Jefferson University."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with metastatic uveal melanoma (MUM) in the liver usually die within 1 year. The development of new treatments for MUM has been limited by the lack of diverse MUM cell lines and appropriate animal models. We previously reported that orthotopic xenograft mouse models established by direct injection of MUM cells into the liver were useful for the analysis associated with tumor microenvironment in the liver. However, considering that patients with UM metastasize to the liver hematogenously, direct liver injection model might not be suitable for investigation on various mechanisms of liver metastasis. Here, we aim to establish new orthotopic xenograft models via hematogenous dissemination of tumor cells to the liver, and to compare their characteristics with the hepatic injection model. We also determine if hepatic tumors could be effectively monitored with non-invasive live imaging.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>tdtTomate-labeled, patient-derived MUM cells were injected into the liver, spleen or tail vein of immunodeficient NSG mice. Tumor growth was serially assessed with In Vivo Imaging System (IVIS) images once every week. Established hepatic tumors were evaluated with CT scan and then analyzed histologically.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that splenic injection could consistently establish hepatic tumors. Non-invasive imaging showed that the splenic injection model had more consistent and stronger fluorescent intensity compared to the hepatic injection model. There were no significant differences in tumor growth between splenic injection with splenectomy and without splenectomy. The splenic injection established hepatic tumors diffusely throughout the liver, while the hepatic injection of tumor cells established a single localized tumor. Long-term monitoring of tumor development showed that tumor growth, tumor distribution in the liver, and overall survival depended on the number of tumor cells injected to the spleen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We established a new orthotopic hepatic metastatic xenograft mouse model by splenic injection of MUM cells. The growth of orthotopic hepatic tumors could be monitored with non-invasive IVIS imaging. Moreover, we evaluated the therapeutic effect of a MEK inhibitor by using this model. Our findings suggest that our new orthotopic liver metastatic mouse model may be useful for preclinical drug screening experiments and for the analysis of liver metastasis mechanisms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-020-02377-x","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T12:03:04Z","timestamp":1589976184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma"],"prefix":"10.1186","volume":"18","author":[{"given":"Takahito","family":"Sugase","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao Q.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meggie","family":"Danielson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizue","family":"Terai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew E.","family":"Aplin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Silvio","family":"Gutkind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takami","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"key":"2377_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10555-017-9663-3","volume":"36","author":"A Amaro","year":"2017","unstructured":"Amaro A, Gangemi R, Piaggio F, Angelini G, Barisione G, Ferrini S, Pfeffer U. The\u00a0biology\u00a0of\u00a0uveal melanoma. Cancer Metastasis Rev. 2017;36:109\u201340.","journal-title":"Cancer Metastasis Rev"},{"key":"2377_CR2","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/cncr.29727","volume":"122","author":"C Chattopadhyay","year":"2016","unstructured":"Chattopadhyay C, Kim DW, Gombos DS, Oba J, Qin Y, Williams MD, Esmaeli B, Grimm EA, Wargo JA, Woodman SE, Patel SP. Uveal melanoma: from diagnosis to treatment and the science in between. Cancer. 2016;122:2299\u2013312.","journal-title":"Cancer"},{"key":"2377_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/OPTH.S89591","volume":"11","author":"BA Krantz","year":"2017","unstructured":"Krantz BA, Dave N, Komatsubara KM, Marr BP, Carvajal RD. Uveal melanoma: epidemiology, etiology, and treatment of primary disease. Clin Ophthalmol. 2017;11:279\u201389.","journal-title":"Clin Ophthalmol"},{"key":"2377_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0161-6420(91)32285-1","volume":"98","author":"ES Gragoudas","year":"1991","unstructured":"Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, Munzenrider JE, Spar MD. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991;98:383\u20139.","journal-title":"Ophthalmology"},{"key":"2377_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ohc.2004.07.003","volume":"18","author":"AD Singh","year":"2005","unstructured":"Singh AD, Borden EC. Metastatic uveal melanoma. Ophthalmol Clin North Am. 2005;18:143\u201350.","journal-title":"Ophthalmol Clin North Am"},{"key":"2377_CR6","doi-asserted-by":"crossref","first-page":"175883401875717","DOI":"10.1177\/1758834018757175","volume":"10","author":"J Yang","year":"2018","unstructured":"Yang J, Manson DK, Marr BP, Carvajal RD. Treatment of uveal melanoma: where are we now? Ther Adv Med Oncol. 2018;10:1758834018757175.","journal-title":"Ther Adv Med Oncol"},{"key":"2377_CR7","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/archopht.126.10.1413","volume":"126","author":"G Virgili","year":"2008","unstructured":"Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM. Survival in patients with uveal melanoma in Europe. Arch Ophthalmol. 2008;126:1413\u20138.","journal-title":"Arch Ophthalmol"},{"key":"2377_CR8","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011;118:1881\u20135.","journal-title":"Ophthalmology"},{"key":"2377_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/ceo.12490","volume":"43","author":"AL Chew","year":"2015","unstructured":"Chew AL, Spilsbury K, Isaacs TW. Survival from uveal melanoma in Western Australia 1981\u20132005. Clin Exp Ophthalmol. 2015;43:422\u20138.","journal-title":"Clin Exp Ophthalmol"},{"key":"2377_CR10","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1136\/bjophthalmol-2015-306810","volume":"99","author":"MT Andreoli","year":"2015","unstructured":"Andreoli MT, Mieler WF, Leiderman YI. Epidemiological\u00a0trends\u00a0in\u00a0uveal melanoma. Br J Ophthalmol. 2015;99:1550\u20133.","journal-title":"Br J Ophthalmol"},{"key":"2377_CR11","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1158\/1535-7163.MCT-13-0550","volume":"13","author":"E Musi","year":"2014","unstructured":"Musi E, Ambrosini G, de Stanchina E, Schwartz GK. The phosphoinositide 3-kinase \u03b1 selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ\/GNA11-mutant uveal melanoma cells. Mol Cancer Ther. 2014;13:1044\u201353.","journal-title":"Mol Cancer Ther"},{"key":"2377_CR12","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.18632\/oncotarget.6500","volume":"7","author":"H Yang","year":"2016","unstructured":"Yang H, Brackett CM, Morales-Tirado VM, Li Z, Zhang Q, Wilson MW, Benjamin C, Harris W, Waller EK, Gudkov AV, et al. The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism. Oncotarget. 2016;7:2936\u201350.","journal-title":"Oncotarget"},{"key":"2377_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1076\/ceyr.18.2.125.5380","volume":"18","author":"CE Diaz","year":"1999","unstructured":"Diaz CE, Ruscianom D, Dithmar S, Grossniklaus HE. B16LS9\u00a0melanoma cells spread to the liver from the murine ocular posterior compartment (PC). Curr Eye Res. 1999;18:125\u20139.","journal-title":"Curr Eye Res"},{"key":"2377_CR14","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/sj.bjc.6600919","volume":"88","author":"SC Edmunds","year":"2003","unstructured":"Edmunds SC, Cree IA, D\u00ed N\u00edcolanton\u00edo F, Hungerford JL, Hurren JS, Kelsell DP. Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas. Br J Cancer. 2003;88:1403\u20135.","journal-title":"Br J Cancer"},{"key":"2377_CR15","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/s41388-017-0018-x","volume":"37","author":"A Blomme","year":"2018","unstructured":"Blomme A, Van Simaeys G, Doumont G, Costanza B, Bellier J, Otaka Y, Sherer F, Lovinfosse P, Boutry S, Palacios AP, et al. Murine stroma adopts a human-like metabolic phenotype in the\u00a0PDX\u00a0model of colorectal\u00a0cancer\u00a0and liver metastases. Oncogene. 2018;37:1237\u201350.","journal-title":"Oncogene"},{"key":"2377_CR16","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809081","author":"V Chua","year":"2019","unstructured":"Chua V, Orloff M, Teh JL, Sugase T, Liao C, Purwin TJ, Lam BQ, Terai M, Ambrosini G, Carvajal RD, et al. Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma. EMBO Mol Med. 2019. https:\/\/doi.org\/10.15252\/emmm.201809081.","journal-title":"EMBO Mol Med"},{"key":"2377_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/clpt.2008.200","volume":"85","author":"B Rubio-Viqueira","year":"2009","unstructured":"Rubio-Viqueira B, Hidalgo M. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients. Clin Pharmacol Ther. 2009;85:217\u201321.","journal-title":"Clin Pharmacol Ther"},{"key":"2377_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12967-017-1247-z","volume":"15","author":"K Kageyama","year":"2017","unstructured":"Kageyama K, Ohara M, Saito K, Ozaki S, Terai M, Mastrangelo MJ, Fortina P, Aplin AE, Sato T. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis. J Transl Med. 2017;15:145.","journal-title":"J Transl Med"},{"key":"2377_CR19","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1158\/0008-5472.CAN-15-0370","volume":"75","author":"H Cheng","year":"2015","unstructured":"Cheng H, Terai M, Kageyama K, Ozaki S, McCue PA, Sato T, Aplin AE. Paracrine effect of NRG1 and HGF Drives resistance to MEK inhibitors in metastatic uveal melanoma. Cancer Res. 2015;75:2737\u201348.","journal-title":"Cancer Res"},{"key":"2377_CR20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1158\/1535-7163.MCT-16-0552","volume":"16","author":"H Cheng","year":"2017","unstructured":"Cheng H, Chua V, Liao C, Purwin TJ, Terai M, Kageyama K, Davies MA, Sato T, Aplin AE. Co-targeting HGF\/cMET signaling with MEK inhibitors in metastatic uveal melanoma. Mol Cancer Ther. 2017;16:516\u201328.","journal-title":"Mol Cancer Ther"},{"key":"2377_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/pcmr.12206","volume":"27","author":"M Yoshida","year":"2014","unstructured":"Yoshida M, Selvan S, McCue PA, DeAngelis T, Baserga R, Fujii A, Rui H, Mastrangelo MJ, Sato T. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth. Pigment Cell Melanoma Res. 2014;27:297\u2013308.","journal-title":"Pigment Cell Melanoma Res"},{"key":"2377_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ajpath.2015.09.011","volume":"186","author":"S Ozaki","year":"2016","unstructured":"Ozaki S, Vuyyuru R, Kageyama K, Terai M, Ohara M, Cheng H, Manser T, Mastrangelo MJ, Aplin AE, Sato T. Establishment and characterization of\u00a0orthotopic\u00a0mouse models for human uveal melanoma hepatic colonization. Am J Pathol. 2016;186:43\u201356.","journal-title":"Am J Pathol"},{"key":"2377_CR23","doi-asserted-by":"publisher","first-page":"e25692","DOI":"10.1371\/journal.pone.0025692","volume":"6","author":"H Boll","year":"2011","unstructured":"Boll H, Nittka S, Doyon F, Neumaier M, Marx A, Kramer M, Groden C, Brockmann MA. Micro-CT based experimental liver imaging using a nanoparticulate contrast agent: a longitudinal study in mice. PLoS ONE. 2011;6:e25692.","journal-title":"PLoS ONE"},{"key":"2377_CR24","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1097\/PAS.0b013e3181658c14","volume":"32","author":"D Nonaka","year":"2008","unstructured":"Nonaka D, Chiriboga L, Rubin BP. Sox10: a pan-schwannian and melanocytic marker. Am J Surg Pathol. 2008;32:1291\u20138.","journal-title":"Am J Surg Pathol"},{"key":"2377_CR25","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1111\/j.1600-0625.2009.00991.x","volume":"19","author":"RM Bakos","year":"2010","unstructured":"Bakos RM, Maier T, Besch R, Mestel DS, Ruzicka T, Sturm RA, Berking C. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma. Exp Dermatol. 2010;19:e89\u201394.","journal-title":"Exp Dermatol"},{"key":"2377_CR26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3332\/ecancer.2015.566","volume":"9","author":"SA Alghamdi","year":"2015","unstructured":"Alghamdi SA, Zoroquiain P, Dias AB, Alhumaid SR, Aldrees S, Burnier MN Jr. Diagnostic\u00a0value\u00a0of\u00a0SOX-10\u00a0immunohistochemical\u00a0staining\u00a0for the\u00a0detection\u00a0of\u00a0uvealmelanoma. Ecancermedicalscience. 2015;9:566.","journal-title":"Ecancermedicalscience"},{"key":"2377_CR27","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1167\/iovs.17-22362","volume":"58","author":"T Mori","year":"2017","unstructured":"Mori T, Sukeda A, Sekine S, Shibata S, Ryo E, Okano H, Suzuki S, Hiraoka N. SOX10 expression as well as BRAF and GNAQ\/11 mutations distinguish pigmented ciliary epithelium neoplasms from\u00a0uveal\u00a0melanomas. Invest Ophthalmol Vis Sci. 2017;58:5445\u201351.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2377_CR28","doi-asserted-by":"publisher","first-page":"8458","DOI":"10.1167\/iovs.11-7379","volume":"52","author":"H Kalirai","year":"2011","unstructured":"Kalirai H, Damato BE, Coupland SE. Uveal\u00a0melanoma\u00a0cell\u00a0lines\u00a0contain\u00a0stem-like\u00a0cells\u00a0that\u00a0self-renew,\u00a0produce\u00a0differentiated progeny, and\u00a0survive\u00a0chemotherapy. Invest Ophthalmol Vis Sci. 2011;52:8458\u201366.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2377_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091875","author":"RM Hoffman","year":"2017","unstructured":"Hoffman RM. Patient-derived\u00a0orthotopic\u00a0xenograft\u00a0(PDOX) models of melanoma. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18091875.","journal-title":"Int J Mol Sci"},{"key":"2377_CR30","first-page":"5179","volume":"16","author":"HY Feng","year":"2018","unstructured":"Feng HY, Zhang Y, Liu HJ, Dong X, Yang SC, Lu Q, Meng F, Chen HZ, Sun P, Fang C. Characterization of an orthotopic gastric cancer mouse model with lymph node and organ metastases using bioluminescence imaging. Oncol Lett. 2018;16:5179\u201385.","journal-title":"Oncol Lett"},{"key":"2377_CR31","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3892\/ijo.2017.4115","volume":"51","author":"J Guo","year":"2017","unstructured":"Guo J, Cai J, Zhang Y, Zhu Y, Yang P, Wang Z. Establishment of two ovarian cancer orthotopic xenograft mouse models for in vivo imaging: a comparative study. Int J Oncol. 2017;51:1199\u2013208.","journal-title":"Int J Oncol"},{"key":"2377_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/MPA.0000000000000843","volume":"46","author":"KL Go","year":"2017","unstructured":"Go KL, Delitto D, Judge SM, Gerber MH, George TJ Jr, Behrns KE, Hughes SJ, Judge AR, Trevino JG. Orthotopic patient-derived pancreatic cancer xenografts engraft into the pancreatic parenchyma, metastasize, and induce muscle wasting to recapitulate the human disease. Pancreas. 2017;46:813\u20139.","journal-title":"Pancreas"},{"issue":"6","key":"2377_CR33","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/j.1464-410X.2007.07165.x","volume":"100","author":"Boris A. Hadaschik","year":"2007","unstructured":"Hadaschik Ba, Black PC, Sea JC, Metwalli AR, Fazli L, Dinney CP, Gleave ME, So AI. A\u00a0validated\u00a0mouse\u00a0model\u00a0for\u00a0orthotopic\u00a0bladder\u00a0cancer\u00a0using\u00a0transurethral\u00a0tumour inoculation and\u00a0bioluminescence\u00a0imaging. BJU Int. 2007;100:1377-84.","journal-title":"BJU International"},{"key":"2377_CR34","doi-asserted-by":"publisher","DOI":"10.21769\/bioprotoc.2311","author":"HW Liao","year":"2017","unstructured":"Liao HW, Hung MC. Intracaecal\u00a0orthotopic\u00a0colorectal cancer\u00a0xenograft\u00a0mouse model. Bio Protoc. 2017. https:\/\/doi.org\/10.21769\/bioprotoc.2311.","journal-title":"Bio Protoc"},{"key":"2377_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.humpath.2016.07.012","volume":"57","author":"HE Grossniklaus","year":"2016","unstructured":"Grossniklaus HE, Zhang Q, You S, McCarthy C, Heegaard S, Coupland SE. Metastatic\u00a0ocular\u00a0melanoma\u00a0to the liver exhibits infiltrative and nodular growth patterns. Hum Pathol. 2016;57:165\u201375.","journal-title":"Hum Pathol"},{"key":"2377_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.20517\/2394-4722.2017.39","volume":"3","author":"M Terai","year":"2017","unstructured":"Terai M, Mastrangleo MJ, Sato T. Immunological aspect of the liver and metastatic uveal melanoma. J Cancer Metastasis Treat. 2017;3:231\u201343.","journal-title":"J Cancer Metastasis Treat"},{"issue":"2","key":"2377_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.14348\/molcells.2016.2350","volume":"39","author":"SY Cho","year":"2016","unstructured":"Cho SY, Kang W, Han JY, Min S, Kang J, Lee A, Kwon JY, Lee C, Park H. An integrative approach to precision cancer medicine using patient-derived xenografts. Mol Cells. 2016;39(2):77\u201386.","journal-title":"Mol Cells"},{"key":"2377_CR38","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1002\/ijc.30666","volume":"140","author":"T Sugase","year":"2017","unstructured":"Sugase T, Takahashi T, Serada S, Nakatsuka R, Fujimoto M, Ohkawara T, Hara H, Nishigaki T, Tanaka K, Miyazaki Y, et al. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice. Int J Cancer. 2017;140:2608\u201321.","journal-title":"Int J Cancer"},{"key":"2377_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.gde.2013.11.012","volume":"24","author":"N Sachs","year":"2014","unstructured":"Sachs N, Clevers H. Organoid\u00a0cultures for the analysis of\u00a0cancer\u00a0phenotypes. Curr Opin Genet Dev. 2014;24:68\u201373.","journal-title":"Curr Opin Genet Dev"},{"key":"2377_CR40","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.chembiol.2017.06.012","volume":"24","author":"F Weeber","year":"2017","unstructured":"Weeber F, Ooft SN, Dijkstra KK, Voest EE. Tumor organoids as a pre-clinical cancer model for drug discovery. Cell Chem Biol. 2017;24:1092\u2013100.","journal-title":"Cell Chem Biol"},{"issue":"1","key":"2377_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13045-017-0470-7","volume":"10","author":"Y Lai","year":"2017","unstructured":"Lai Y, Wei X, Lin S, Qin L, Cheng L, Li P. Current status and perspectives of patient-derived xenograft models in cancer research. J Hematol Oncol. 2017;10(1):106.","journal-title":"J Hematol Oncol"},{"key":"2377_CR42","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10456-012-9291-z","volume":"15","author":"JC Welti","year":"2012","unstructured":"Welti JC, Powles T, Foo S, Gourlaouen M, Preece N, Foster J, Frentzas S, Bird D, Sharpe K, van Weverwijk A. Contrasting\u00a0effects of\u00a0sunitinib\u00a0within\u00a0in vivo\u00a0models of metastasis. Angiogenesis. 2012;15:623\u201341.","journal-title":"Angiogenesis"},{"key":"2377_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1479-5876-12-41","volume":"12","author":"JK Sicklick","year":"2014","unstructured":"Sicklick JK, Leonard SY, Babicky ML, Tang CM, Mose ES, French RP, Jaquish DV, Hoh CK, Peterson M, Schwab R, Lowy AM. Generation\u00a0of\u00a0orthotopic\u00a0patient-derived\u00a0xenografts\u00a0from\u00a0gastrointestinal\u00a0stromal\u00a0tumor. J Transl Med. 2014;12:41.","journal-title":"J Transl Med"},{"issue":"4","key":"2377_CR44","doi-asserted-by":"publisher","first-page":"e1409929","DOI":"10.1080\/2162402X.2017.1409929","volume":"7","author":"F Foerster","year":"2017","unstructured":"Foerster F, Boegel S, Heck R, Pickert G, R\u00fcssel N, Rosigkeit S, Bros M, Strobl S, Kaps L, Aslam M, Diken M, Castle J, Sahin U, Tuettenberg A, Bockamp E, Schuppan D. Enhanced protection of C57 BL\/6 vs Balb\/c mice to\u00a0melanoma\u00a0liver\u00a0metastasis is mediated by NK cells. Oncoimmunology. 2017;7(4):e1409929.","journal-title":"Oncoimmunology"},{"issue":"12","key":"2377_CR45","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.neo.2018.10.001","volume":"20","author":"KM Schmidt","year":"2018","unstructured":"Schmidt KM, Dietrich P, Hackl C, Guenzle J, Bronsert P, Wagner C, Fichtner-Feigl S, Schlitt HJ, Geissler EK, Hellerbrand C, Lang SA. Inhibition of mTORC2\/RICTOR impairs\u00a0melanoma\u00a0hepatic metastasis. Neoplasia. 2018;20(12):1198\u2013208.","journal-title":"Neoplasia"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02377-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-020-02377-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02377-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T07:26:48Z","timestamp":1621495608000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02377-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2377"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02377-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"assertion":[{"value":"31 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study was approved by the Institutional Animal Care and Use Committee (IACUC) of Thomas Jefferson University (protocol # 1587) and adhered to the recommendations in the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"208"}}